In this Section |
220366 Adapting evidence-based intervention in a Community Health Center (CHC): Opportunities and challengesMonday, November 8, 2010
Introduction: Community health centers (CHCs) provide primary care to many low income, underserved, and vulnerable populations. Adaptation of evidence-based interventions (EBIs) into practice offers an opportunity to improve the care of the diverse CHC patients. Methods: We are conducting 15 key informant interviews with the staff of a CHC to examine the adaptation, implementation, and maintenance of an EBI to promote colorectal cancer screening. The interviews are conducted with CHC staff with different roles and levels of responsibility. The staff participated in the interview included clinical staff, providers, supervisors, directors, and decision makers. Each interview lasted for an hour. All interviews were audio recorded, transcribed verbatim, and imported to Atlas.ti for further analysis. Results: A majority of the staff interviewed agreed and welcomed the idea of incorporating EBIs into their work. Staffs at the management level and the providers are more familiar with the term EBI. Clinical staff is more concerned with the EBI's impact on their daily operations whereas management level staff related more to the organization's goals and mission as well as the population served. Conclusion: Adaptation of EBIs must consider their successful integration with routine and existing organizational structure. To achieve long - term sustainability, EBIs must also demonstrate their added value by addressing the CHCs' goals to improve patient outcomes.
Learning Areas:
Conduct evaluation related to programs, research, and other areas of practiceLearning Objectives: Keywords: Cancer Prevention, Quality Improvement
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I am the co-investigator of this project. I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
Back to: 3081.2: Public Health Perspectives on Cancer Treatment and Survivorship
|